PROTOCOL: A cohort study examining the association between mirtazapine and mortality risk in adults with a diagnosis of depression
Joseph, R. M.; Jack, R. H.; Morriss, R.; Knaggs, R. D.; Hollis, C.; Hippisley-Cox, J.; Coupland, C.
Show abstract
This protocol describes a cohort study comparing the risks of mortality and serious self-harm (suicide or near-fatal deliberate self-harm) between adults with depression prescribed mirtazapine, a selective serotonin reuptake inhibitor (SSRI), amitriptyline, or venlafaxine. The study is set within English primary care electronic health records from the Clinical Practice Research Datalink (CPRD) and covers the period 01 January 2005 - 30 November 2018. The study described uses an active comparator new user design: patients are included if they are first prescribed an SSRI before being prescribed mirtazapine, a different SSRI, amitriptyline, or venlafaxine as their second antidepressant. Patients are followed from the initial prescription for the second antidepressant until an outcome (mortality, serious self-harm), end of CPRD follow-up, or study end. Inverse probability of treatment weighting is used to account for confounding variables. The protocol was submitted to the CPRD Independent Scientific Advisory Committee for review and was approved in November 2019 (protocol number 19_241).
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Global prevalence of antidepressant utilization in the community: A protocol for a systematic review 97%
- Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysis 96%
- The Antidepressant Advisor (ADeSS): A Decision Support System for Antidepressant Treatment for Depression in UK primary care – a feasibility study 94%
Similar papers in this journal
- Predicting intentions towards long-term antidepressant use in the management of people with depression in primary care: A longitudinal survey study 95%
- Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents With Suicidal Ideation Associated With Major Depressive Disorder: Protocol for a Randomized Controlled Trial 95%
- Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders 95%
Similar papers in this journal
- Longitudinal effects of using and discontinuing CNS medications on cognitive functioning 92%
- Benzodiazepine Initiation Effect on Mortality Among Medicare Beneficiaries Post Acute Ischemic Stroke 90%
- Pregnancy pharmacoepidemiology: How often are key methodological elements reported in publications? 90%
Similar papers in this journal
- The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism: An interrupted time-series analysis in England using OpenSAFELY-TPP 95%
- The development and validation of a prognostic model to predict relapse in adults with remitted depression in primary care: secondary analysis of pooled individual participant data from multiple studies 94%
- Co-prescription of Metformin and Antipsychotics in Severe Mental Illness: A UK Primary Care Cohort Study 93%
Similar papers in this journal
- Efficacy and safety of esketamine for treatment resistant depression: registered report for a Systematic Review with an Individual Patient Data Meta-analysis of Randomized, Double-Blind, Placebo-Controlled Trials 94%
- Establishing the causal role of intimate partner violence and abuse on depressive symptoms in young adults: a population-based cohort study 91%
- Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009. 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.